Table 6.
Indications on the selection of the most adequate NSAID according to the cardiovascular and gastrointestinal risk, in patients with high renal risk
| High renal risk | ||
|---|---|---|
| CV risk | GI risk | |
| Low | High | |
| Low | Diclofenac/other selective COX-2 inhibitors at the lowest effective level, for no longer than 7 to 10 days | Any NSAID |
| High | Any NSAID | Any NSAID |
| High + LDA | Any NSAID | Any NSAID |
In italics, compounds indicated based on the available randomized controlled trials. Underlined, compounds contraindicated based on the available randomized controlled trials
GI gastrointestinal, COX-2 cyclooxygenase, NSAID non-steroidal anti-inflammatory drug, CV cardiovascular, LDA low-dose aspirin